Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.41476 | 16 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.32727 | 13 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.32705 | 13 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.26521 | 12 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.39462 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.36091 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.33098 | 12 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.30433 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.30995 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.30843 | 13 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.31654 | 13 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.30252 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.31761 | 13 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.31138 | 13 |